Bressler L R, Geraci M C, Schatz B S
Department of Pharmacy Practice, College of Pharmacy, University of Illinois, Chicago 60612.
DICP. 1991 Nov;25(11):1225-30. doi: 10.1177/106002809102501112.
This article examines misperceptions and barriers to adequate pain relief in cancer patients. Healthcare professionals have gaps in their knowledge of opioid drugs as well as misconceptions concerning tolerance, physical dependence, and addiction that often lead to the underprescribing of these agents. The pervasiveness of the "say no to drugs" message in our society and the fear of addiction on the part of patients and their families creates yet another barrier to the legitimate use of opioids to treat cancer pain. Legal and regulatory documents filled with arbitrary and ill-defined labels meant to promote the legitimate use of these drugs and curtail their misuse may instead intimidate healthcare professionals and negatively influence prescribing habits. Increased educational efforts for pharmacists and other healthcare professionals as well as the development of clinical role models and state cancer pain initiatives are cited as means to break down these barriers in order to achieve adequate pain relief for all cancer patients.
本文探讨了癌症患者在获得充分疼痛缓解方面的误解和障碍。医疗保健专业人员在阿片类药物知识方面存在差距，同时对耐受性、身体依赖性和成瘾存在误解，这往往导致这些药物的处方不足。我们社会中“对药物说不”信息的普遍存在，以及患者及其家属对成瘾的恐惧，为合法使用阿片类药物治疗癌症疼痛又制造了一道障碍。充斥着随意且定义不明确标签的法律和监管文件，本意是促进这些药物的合法使用并减少其滥用，却可能吓到医疗保健专业人员，并对处方习惯产生负面影响。有人指出，加强对药剂师和其他医疗保健专业人员的教育工作，以及发展临床榜样和州癌症疼痛倡议，是打破这些障碍的手段，以便为所有癌症患者实现充分的疼痛缓解。
